Dorota Skowyra
Associate Professor of Biochemistry and Molecular Biology

EDUCATION:
Ph.D., 1991, University of Gdansk, Poland

MEMBERSHIPS:
American Society for Biochemistry and Molecular Biology

HONORS:
Award of the President of Gdansk University for Ph.D. Thesis
FEBS Youth Travel Award 1991
Post-doctoral Fogarty International Fellowship 1991-95

RESEARCH SUMMARY:

The 26S proteasome is a highly conserved ATP-dependent protease that has a central role in the control of protein stability in all eukaryotic organisms. Among the key biological processes that are controlled by the 26S proteasome are the cell division cycle, cell growth and differentiation, signal transduction, gene expression, DNA repair, stress and immunological responses, and function of the nervous system (circadian rhythms and acquisition of memory). Perturbations of the 26S proteasome-dependent protein degradation pathway are implicated in the pathogenesis of cancer, senescence, viral infection, and major neurodegenerative diseases.

My lab is broadly interested in understanding the molecular mechanism by which the 26S proteasome recruits substrates and initiates their destruction. We currently address this goal by biochemical dissection of protein ubiquitination and degradation in vitro, using purified substrates and components of the SCF ubiquitination pathway of yeast S. cerevisiae (Skowyra et al. 1997, Skowyra et al. 1999). This pathway is conserved and controls degradation of major G1 cell cycle regulatory proteins and signaling molecules in all organisms, from yeast to humans. The knowledge obtained with yeast is therefore directly relevant to the understanding of SCF-mediated proteolysis in human cells. In our studies, we seek to uncover features of the proteasome that could serve as targets for pharmacological regulation of its activity at the steps of substrate recognition and its processing for degradation, but not the degradation itself. This knowledge may be of a considerable significance for development of novel strategies for targeting the proteasome in cancer and other diseases linked to abnormal protein degradation.